Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia

on behalf of the Thalassemia Clinical Research Network

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Pulmonary hypertension (PH) commonly develops in thalassaemia syndromes, but is poorly characterized. The goal of this study was to provide a comprehensive description of the cardiopulmonary and biological profile of patients with thalassaemia at risk for PH. A case-control study of thalassaemia patients at high versus low PH-risk was performed. A single cross-sectional measurement for variables reflecting cardiopulmonary status and biological pathophysiology were obtained, including Doppler-echocardiography, 6-min-walk-test, Borg Dyspnoea Score, New York Heart Association functional class, cardiac magnetic resonance imaging (MRI), chest-computerized tomography, pulmonary function testing and laboratory analyses targeting mechanisms of coagulation, inflammation, haemolysis, adhesion and the arginine-nitric oxide pathway. Twenty-seven thalassaemia patients were evaluated, 14 with an elevated tricuspid-regurgitant-jet-velocity (TRV) ≥ 2·5 m/s. Patients with increased TRV had a higher frequency of splenectomy, and significantly larger right atrial size, left atrial volume and left septal-wall thickness on echocardiography and/or MRI, with elevated biomarkers of abnormal coagulation, lactate dehydrogenase (LDH) levels and arginase concentration, and lower arginine-bioavailability compared to low-risk patients. Arginase concentration correlated significantly to several echocardiography/MRI parameters of cardiovascular function in addition to global-arginine-bioavailability and biomarkers of haemolytic rate, including LDH, haemoglobin and bilirubin. Thalassaemia patients with a TRV ≥ 2·5 m/s have additional echocardiography and cardiac-MRI parameters suggestive of right and left-sided cardiac dysfunction. In addition, low arginine bioavailability may contribute to cardiopulmonary dysfunction in β-thalassaemia.

Original languageEnglish (US)
Pages (from-to)887-898
Number of pages12
JournalBritish Journal of Haematology
Volume169
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Thalassemia
Arginine
Pulmonary Hypertension
Magnetic Resonance Imaging
Biological Availability
Echocardiography
Arginase
L-Lactate Dehydrogenase
Biomarkers
Doppler Echocardiography
Splenectomy
Hemolysis
Bilirubin
Dyspnea
Case-Control Studies
Nitric Oxide
Hemoglobins
Thorax
Tomography
Inflammation

Keywords

  • Arginase
  • Global arginine bioavailability ratio
  • Haemolysis
  • Pulmonary hypertension
  • β-thalassaemia

ASJC Scopus subject areas

  • Hematology

Cite this

on behalf of the Thalassemia Clinical Research Network. / Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. In: British Journal of Haematology. 2015 ; Vol. 169, No. 6. pp. 887-898.
@article{9469b4459d96450d96f32c1a50966724,
title = "Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia",
abstract = "Pulmonary hypertension (PH) commonly develops in thalassaemia syndromes, but is poorly characterized. The goal of this study was to provide a comprehensive description of the cardiopulmonary and biological profile of patients with thalassaemia at risk for PH. A case-control study of thalassaemia patients at high versus low PH-risk was performed. A single cross-sectional measurement for variables reflecting cardiopulmonary status and biological pathophysiology were obtained, including Doppler-echocardiography, 6-min-walk-test, Borg Dyspnoea Score, New York Heart Association functional class, cardiac magnetic resonance imaging (MRI), chest-computerized tomography, pulmonary function testing and laboratory analyses targeting mechanisms of coagulation, inflammation, haemolysis, adhesion and the arginine-nitric oxide pathway. Twenty-seven thalassaemia patients were evaluated, 14 with an elevated tricuspid-regurgitant-jet-velocity (TRV) ≥ 2·5 m/s. Patients with increased TRV had a higher frequency of splenectomy, and significantly larger right atrial size, left atrial volume and left septal-wall thickness on echocardiography and/or MRI, with elevated biomarkers of abnormal coagulation, lactate dehydrogenase (LDH) levels and arginase concentration, and lower arginine-bioavailability compared to low-risk patients. Arginase concentration correlated significantly to several echocardiography/MRI parameters of cardiovascular function in addition to global-arginine-bioavailability and biomarkers of haemolytic rate, including LDH, haemoglobin and bilirubin. Thalassaemia patients with a TRV ≥ 2·5 m/s have additional echocardiography and cardiac-MRI parameters suggestive of right and left-sided cardiac dysfunction. In addition, low arginine bioavailability may contribute to cardiopulmonary dysfunction in β-thalassaemia.",
keywords = "Arginase, Global arginine bioavailability ratio, Haemolysis, Pulmonary hypertension, β-thalassaemia",
author = "{on behalf of the Thalassemia Clinical Research Network} and Morris, {Claudia R.} and Kim, {Hae Young} and Klings, {Elizabeth S.} and John Wood and Porter, {John B.} and Felicia Trachtenberg and Nancy Sweeters and Olivieri, {Nancy F.} and Kwiatkowski, {Janet L.} and Lisa Virzi and Kathryn Hassell and Ali Taher and Neufeld, {Ellis J.} and Thompson, {Alexis A.} and Sandra Larkin and Suh, {Jung H.} and Vichinsky, {Elliott P.} and Kuypers, {Frans A.} and Ellis Neufeld",
year = "2015",
month = "6",
day = "1",
doi = "10.1111/bjh.13452",
language = "English (US)",
volume = "169",
pages = "887--898",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. / on behalf of the Thalassemia Clinical Research Network.

In: British Journal of Haematology, Vol. 169, No. 6, 01.06.2015, p. 887-898.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia

AU - on behalf of the Thalassemia Clinical Research Network

AU - Morris, Claudia R.

AU - Kim, Hae Young

AU - Klings, Elizabeth S.

AU - Wood, John

AU - Porter, John B.

AU - Trachtenberg, Felicia

AU - Sweeters, Nancy

AU - Olivieri, Nancy F.

AU - Kwiatkowski, Janet L.

AU - Virzi, Lisa

AU - Hassell, Kathryn

AU - Taher, Ali

AU - Neufeld, Ellis J.

AU - Thompson, Alexis A.

AU - Larkin, Sandra

AU - Suh, Jung H.

AU - Vichinsky, Elliott P.

AU - Kuypers, Frans A.

AU - Neufeld, Ellis

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Pulmonary hypertension (PH) commonly develops in thalassaemia syndromes, but is poorly characterized. The goal of this study was to provide a comprehensive description of the cardiopulmonary and biological profile of patients with thalassaemia at risk for PH. A case-control study of thalassaemia patients at high versus low PH-risk was performed. A single cross-sectional measurement for variables reflecting cardiopulmonary status and biological pathophysiology were obtained, including Doppler-echocardiography, 6-min-walk-test, Borg Dyspnoea Score, New York Heart Association functional class, cardiac magnetic resonance imaging (MRI), chest-computerized tomography, pulmonary function testing and laboratory analyses targeting mechanisms of coagulation, inflammation, haemolysis, adhesion and the arginine-nitric oxide pathway. Twenty-seven thalassaemia patients were evaluated, 14 with an elevated tricuspid-regurgitant-jet-velocity (TRV) ≥ 2·5 m/s. Patients with increased TRV had a higher frequency of splenectomy, and significantly larger right atrial size, left atrial volume and left septal-wall thickness on echocardiography and/or MRI, with elevated biomarkers of abnormal coagulation, lactate dehydrogenase (LDH) levels and arginase concentration, and lower arginine-bioavailability compared to low-risk patients. Arginase concentration correlated significantly to several echocardiography/MRI parameters of cardiovascular function in addition to global-arginine-bioavailability and biomarkers of haemolytic rate, including LDH, haemoglobin and bilirubin. Thalassaemia patients with a TRV ≥ 2·5 m/s have additional echocardiography and cardiac-MRI parameters suggestive of right and left-sided cardiac dysfunction. In addition, low arginine bioavailability may contribute to cardiopulmonary dysfunction in β-thalassaemia.

AB - Pulmonary hypertension (PH) commonly develops in thalassaemia syndromes, but is poorly characterized. The goal of this study was to provide a comprehensive description of the cardiopulmonary and biological profile of patients with thalassaemia at risk for PH. A case-control study of thalassaemia patients at high versus low PH-risk was performed. A single cross-sectional measurement for variables reflecting cardiopulmonary status and biological pathophysiology were obtained, including Doppler-echocardiography, 6-min-walk-test, Borg Dyspnoea Score, New York Heart Association functional class, cardiac magnetic resonance imaging (MRI), chest-computerized tomography, pulmonary function testing and laboratory analyses targeting mechanisms of coagulation, inflammation, haemolysis, adhesion and the arginine-nitric oxide pathway. Twenty-seven thalassaemia patients were evaluated, 14 with an elevated tricuspid-regurgitant-jet-velocity (TRV) ≥ 2·5 m/s. Patients with increased TRV had a higher frequency of splenectomy, and significantly larger right atrial size, left atrial volume and left septal-wall thickness on echocardiography and/or MRI, with elevated biomarkers of abnormal coagulation, lactate dehydrogenase (LDH) levels and arginase concentration, and lower arginine-bioavailability compared to low-risk patients. Arginase concentration correlated significantly to several echocardiography/MRI parameters of cardiovascular function in addition to global-arginine-bioavailability and biomarkers of haemolytic rate, including LDH, haemoglobin and bilirubin. Thalassaemia patients with a TRV ≥ 2·5 m/s have additional echocardiography and cardiac-MRI parameters suggestive of right and left-sided cardiac dysfunction. In addition, low arginine bioavailability may contribute to cardiopulmonary dysfunction in β-thalassaemia.

KW - Arginase

KW - Global arginine bioavailability ratio

KW - Haemolysis

KW - Pulmonary hypertension

KW - β-thalassaemia

UR - http://www.scopus.com/inward/record.url?scp=84930275568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930275568&partnerID=8YFLogxK

U2 - 10.1111/bjh.13452

DO - 10.1111/bjh.13452

M3 - Article

VL - 169

SP - 887

EP - 898

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -